Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Targeted Serum Metabolite Profiling Identifies Metabolic Signatures in Patients with Alzheimer's Disease, Normal Pressure Hydrocephalus and Brain Tumor

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Genetic Overlap Between Alzheimer's Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Microstate Changes Associated With Alzheimer's Disease in Persons With Down Syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Microstates as Disease and Progression Markers in Patients With Mild Cognitive Impairment

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces in vivo Neuroreceptor Occupancy and Reduces Striatal Glutamate Levels

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Circulating metabolites in progression to islet autoimmunity and type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Polyols and Branched Chained Amino Acids Are Associated with Present and Future Renal Impairment in Type 1 Diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Circulating metabolites are associated with present and future renal impairment in type 1 Diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations

Progression to AD is preceded by elevated levels of 2,4-dihydroxybutanoic acid (2,4-DHB), implicating hypoxia in early pathogenesis. Since hypoxia may play a role in multiple CNS disorders, we investigated serum metabolite profiles across three disorders, AD, Normal Pressure Hydrocephalus (NPH) and brain tumors (BT). Blood samples were collected from 27 NPH and 20 BT patients. The profiles of 21 metabolites were examined. Additionally, data from 37 AD patients and 46 controls from a previous study were analyzed together with the newly acquired data. No differences in 2,4-DHB were found across AD, NPH and BT samples. In the BT group, the fatty acids were increased as compared to HC and NPH groups, while the ketone body 3-hydroxybutyrate was increased as compared to AD. Glutamic acid was increased in AD as compared to the HC group. In the AD group, 3-hydroxybutyrate tended to be decreased with respect to all other groups (mean values -30% or more), but the differences were not statistically significant. Serine was increased in NPH as compared to BT. In conclusion, AD, NPH and BT have different metabolic profiles. This preliminary study may help in identifying the blood based markers that are specific to these three CNS diseases.

Original languageEnglish
JournalFrontiers in Neuroscience
Volume11
Pages (from-to)747
ISSN1662-4548
DOIs
Publication statusPublished - 9 Jan 2018

    Research areas

  • Journal Article

ID: 52643492